What is CUSIP 053588109?

CUSIP 053588109 is the security identifier used in SEC filing datasets for AVEO - AVEO PHARMACEUTICALS INC - COM.

Who owns AVEO - AVEO PHARMACEUTICALS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

AVEO PHARMACEUTICALS INC - COM (AVEO) Institutional Ownership

CUSIP: 053588109

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2021

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / COM
Symbol: AVEO

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

AVEO - AVEO PHARMACEUTICALS INC - COM is tracked under CUSIP 053588109.
Latest finished 13F holder period is not available.
Schedule 13D/13G significant owner rows are not currently available.

Change

Holder count moved from 1 to 0 between Q2 2021 and Q3 2021.
SEC-reported value moved from $30,000 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

053588109

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

AVEO full holder history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 053588109:

Q3 2021 (0 holders) Q2 2021 (1 holder) Q1 2021 (1 holder) Q4 2020 (1 holder) Q3 2020 (2 holders) Q2 2020 (2 holders) Q1 2020 (2 holders) Q4 2019 (55 holders) Q3 2019 (58 holders) Q2 2019 (68 holders)

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Rows shown

1-25 of 31

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2021 Q3	0	$0	-$30,000				0
2021 Q2	1,939	$30,000				$15.47	1
2021 Q1	1,939	$28,000				$14.44	1
2020 Q4	1,939	$25,000	-$443,000			$12.89	1
2020 Q3	76,491	$462,000	+$51,364			$7.87	2
2020 Q2	67,847	$358,000	-$141,657			$7.47	2
2020 Q1	67,197	$254,000	-$28,084,593	$0	$0	$6.45	2
2019 Q4	42,404,682	$26,504,027	-$677,883	$427,000	$1,028,000	$0.62	55
2019 Q3	42,798,755	$36,170,822	-$3,555,594	$1,106,000	$1,514,000	$0.84	58
2019 Q2	47,488,698	$31,923,086	+$1,360,893	$671,000	$1,446,000	$0.67	68
2019 Q1	45,474,647	$37,290,753	-$7,972,602	$941,000	$2,069,000	$0.82	73
2018 Q4	49,644,694	$79,438,613	-$9,757,762	$2,421,000	$7,623,000	$1.60	92
2018 Q3	50,058,057	$165,780,373	-$25,517,908	$3,226,000	$14,397,000	$3.31	95
2018 Q2	60,147,956	$135,882,361	-$3,533,053	$1,067,000	$9,313,000	$2.26	85
2018 Q1	59,795,578	$173,406,137	-$3,570,322	$1,299,000	$7,519,000	$2.90	83
2017 Q4	61,342,763	$171,307,634	+$150,525	$895,000	$5,044,000	$2.79	83
2017 Q3	59,708,372	$218,044,927	-$7,926,389	$946,000	$5,022,000	$3.65	55
2017 Q2	63,600,286	$141,258,000	+$26,684,563	$79,000	$1,396,000	$2.22	46
2017 Q1	56,232,990	$33,175,472	+$16,881,985		$0	$0.59	41
2016 Q4	29,624,594	$15,994,432	+$396,244		$6,000	$0.54	35
2016 Q3	28,859,272	$25,682,712	-$778,265		$57,000	$0.89	38
2016 Q2	29,653,660	$28,487,769	+$15,210,581			$0.96	41
2016 Q1	13,836,875	$12,727,736	-$144,703	$0		$0.92	32
2015 Q4	13,928,038	$17,553,008	-$1,279,290	$2,000	$0	$1.26	41
2015 Q3	15,570,603	$18,840,968	-$2,204,239	$35,000	$41,000	$1.21	46